Pathophysiology of sepsis-induced cardiomyopathy

SM Hollenberg, M Singer - Nature Reviews Cardiology, 2021 - nature.com
Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to
infection and is the leading cause of death in intensive care units. Cardiac dysfunction …

Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association

SL Chow, AS Maisel, I Anand, B Bozkurt, RA De Boer… - Circulation, 2017 - Am Heart Assoc
Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Mavacamten treatment for obstructive hypertrophic cardiomyopathy: a clinical trial

SB Heitner, D Jacoby, SJ Lester, A Owens… - Annals of internal …, 2019 - acpjournals.org
Background: Mavacamten, an orally administered, small-molecule modulator of cardiac
myosin, targets underlying biomechanical abnormalities in obstructive hypertrophic …

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on …

CW Yancy, M Jessup, B Bozkurt, J Butler… - Journal of the American …, 2013 - jacc.org
2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart …

CW Yancy, M Jessup, B Bozkurt, J Butler, DE Casey Jr… - Circulation, 2013 - Am Heart Assoc
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2011 and includes selected …

2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American …

CW Yancy, M Jessup, B Bozkurt, J Butler, DE Casey Jr… - Circulation, 2017 - Am Heart Assoc
The purpose of this focused update is to update the “2013 ACCF/AHA Guideline for the
Management of Heart Failure” 9 (2013 HF guideline) in areas in which new evidence has …

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and …

WJ Paulus, C Tschöpe, JE Sanderson… - European heart …, 2007 - academic.oup.com
Diastolic heart failure (DHF) currently accounts for more than 50% of all heart failure
patients. DHF is also referred to as heart failure with normal left ventricular (LV) ejection …

Natriuretic peptides

LB Daniels, AS Maisel - Journal of the American college of cardiology, 2007 - jacc.org
Natriuretic peptides (NPs) are released from the heart in response to pressure and volume
overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important …

State of the art: using natriuretic peptide levels in clinical practice

A Maisel, C Mueller, K Adams Jr… - European journal of …, 2008 - Wiley Online Library
Natriuretic peptide (NP) levels (B‐type natriuretic peptide (BNP) and N‐terminal proBNP)
are now widely used in clinical practice and cardiovascular research throughout the world …

Cardiovascular consequences of acute kidney injury

M Legrand, P Rossignol - New England Journal of Medicine, 2020 - Mass Medical Soc
Cardiovascular Consequences of Acute Kidney Injury Acute kidney injury is associated with
many short-and long-term adverse events. This review considers the cardiovascular …